Choose from the list of impairments to see what John Hancock's underwriters look for and likely underwriting risk classifications or rating.
A progressive, malignant disease of the blood cells and blood forming organs (i.e., bone marrow and spleen).
Likely Underwriting Decision
Preferred is not available.
Standard Plus possible after 10 years of qualifying for Standard rates
The most common type of leukemia seen in underwriting is CLL, which is insurable, if stable, low-stage disease and typically after two years since the diagnosis. CLL diagnosed under age 50 is a decline
For other types of leukemia, depending on the type, coverage may not be available for 5 or more years following diagnosis. Very few cases can be offered coverage
Best Case: (CLL cases) 150 to 200% 5-10 years post treatment
Factors Affecting the Decision
- Current Age
- Date of diagnosis
- Type of leukemia and stage of cancer
- Date treatment completed
- Any recurrence or secondary cancer
Fast Track the App
APS, special blood testing if current results are not provided in the APS
- Pathology reports
- Evidence of regular follow-up
- Hospital reports
- Details and date(s) of treatment